Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports

INTRODUCTION: With the expected increase in patients with heart failure and ischemic 15 cardiomyopathy, the development of myocardial regenerative medicine using cell transplantation as a novel treatment method is progressing. This first-in-human clinical trial aimed to confirm the safety of cardiom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Takuji, Ito, Yoshito, Ito, Emiko, Takeda, Maki, Mikami, Tsubasa, Taguchi, Takura, Mochizuki-Oda, Noriko, Sasai, Masao, Shimamoto, Tomomi, Nitta, Yukako, Yoshioka, Daisuke, Kawamura, Masashi, Kawamura, Ai, Misumi, Yusuke, Sakata, Yasushi, Sawa, Yoshiki, Miyagawa, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540447/
https://www.ncbi.nlm.nih.gov/pubmed/37781295
http://dx.doi.org/10.3389/fcvm.2023.1182209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540447/
https://www.ncbi.nlm.nih.gov/pubmed/37781295
http://dx.doi.org/10.3389/fcvm.2023.1182209

Ejemplares similares